Emma C. E. Wassenaar

Author

Also Known As

E C E Wassenaar, E. C. E. Wassenaar, E. Wassenaar, E.C.E. Wassenaar, Emma C E Wassenaar, Emma C. E. Wassenaar, Emma C. Wassenaar, Emma C.E. Wassenaar, Emma CE Wassenaar, Emma Wassenaar

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

St. Antonius Ziekenhuis University Medical Center Utrecht Catharina Ziekenhuis Radboud University Nijmegen The Netherlands Cancer Institute

About

Emma C. E. Wassenaar is an author at St. Antonius Ziekenhuis specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	555
2	Health Sciences	3	3	444
3	Pathology	2	2	142
4	Gastroenterology	1	1	23
5	Immunology	1	1	23

Emma C. E. Wassenaar

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt, The Lancet. Gastroenterology & hepatology Health SciencesGastrointestinal OncologyMedicineRandomised TrialClinical Trials	2019	312
Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases Johannes G. Reiter, Wei‐Ting Hung, I‐Hsiu Lee, Nature Genetics Tumor BiologyLymphoid NeoplasiaTumor HeterogeneityMedicineLymph Node Metastases	2020	119
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6) Koen P. Rovers, Checca Bakkers, Geert A. Simkens, BMC Cancer	2019	108
Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy Inge Ubink, Ana C.F. Bolhaqueiro, Sjoerd G. Elias, British journal of surgery	2019	105
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity Jamila Laoukili, Alexander Constantinides, Emma C. E. Wassenaar, British Journal of Cancer	2022	61
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC) Koen P. Rovers, Emma C. E. Wassenaar, Robin J. Lurvink, Annals of Surgical Oncology Intraperitoneal Aerosol ChemotherapySurgical OncologyPhase Ii TrialGastrointestinal OncologyMedicine	2021	55
Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results Rosa T. van der Kaaij, Emma C. E. Wassenaar, Willem J. Koemans, British journal of surgery	2020	54
Detection of tumor‐derived cell‐free <scp>DNA</scp> from colorectal cancer peritoneal metastases in plasma and peritoneal fluid Iris van ’t Erve, Koen P. Rovers, Alexander Constantinides, The Journal of Pathology Clinical Research	2021	48
Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial Robin J. Lurvink, Rudaba Tajzai, Koen P. Rovers, Annals of Surgical Oncology Intraperitoneal AdministrationSurgical OncologyGastrointestinal OncologyMedicineMetronomic Therapy	2020	33
Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC) Koen P. Rovers, Robin J. Lurvink, Emma C. E. Wassenaar, BMJ Open	2019	30

Page 1